Glycosphingolipid Inhibition and Spermatogenesis in Man: A Pilot Study (MIG 2)
NCT00194649
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Contraception
Interventions
DRUG:
Miglustat (Zavesca)
Sponsor
University of Washington
Collaborators
[object Object]